1,597 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
ABBV AbbVie Inc. $95.37 $144.42B Downtrend
Article Searches
Top Research Reports for Amazon, Verizon & AbbVie http://www.zacks.com/research-daily/207529/top-research-reports-for-amazon-verizon-abbvie?cid=CS-ZC-FT-207529 Jan 23, 2019 - Top Research Reports for Amazon, Verizon & AbbVie
Is a Beat in Store for AbbVie (ABBV) This Earnings Season? http://www.zacks.com/stock/news/349011/is-a-beat-in-store-for-abbvie-abbv-this-earnings-season?cid=CS-ZC-FT-349011 Jan 23, 2019 - AbbVie (ABBV) is likely to beat earnings in fourth quarter. Impressive sales of its key drug, Humira and strong growth of Imbruvica and Mavyret are expected to drive fourth-quarter sales.
Enanta And EDP-305 In NASH: What's In It For AbbVie? https://seekingalpha.com/article/4234823-enanta-edpminus-305-nash-abbvie?source=feed_sector_healthcare Jan 22, 2019 - EDP-305 is presumed to be a new generation Farnesoid X receptor agonist and its lead investigative drug candidate.EDP-305 is a metabolism modulator currently in Phase 2 clinical trials for NASH and Pr
Bet on These 5 Low Leverage Stocks to Secure Returns http://www.zacks.com/stock/news/348794/bet-on-these-5-low-leverage-stocks-to-secure-returns?cid=CS-ZC-FT-348794 Jan 22, 2019 - A high degree of financial leverage means high interest payments, which affect the company's bottom line. So, investors try to avoid stocks that bear large debt loads
AbbVie's Imbruvica Fails in Phase III Pancreatic Cancer Study http://www.zacks.com/stock/news/348733/abbvies-imbruvica-fails-in-phase-iii-pancreatic-cancer-study?cid=CS-ZC-FT-348733 Jan 21, 2019 - AbbVie's (ABBV) Imbruvica falls short of meeting the primary endpoint of PFS or OS benefit in a phase III study that probed its combo usage in first-line metastatic pancreatic cancer.
Despite The Market Rally These Dividend Stocks Are Strong Buys https://seekingalpha.com/article/4234527-despite-market-rally-dividend-stocks-strong-buys?source=feed Jan 21, 2019 - The S&P 500 has had an impressive 13.7% rally since its December 24th lows.Many of the most violently beaten down stocks of the correction are now soaring hard and fast, leaving many investors wonderi
Zacks Value Trader Highlights: Crocs, Five Below, AbbVie and J.Jill http://www.zacks.com/stock/news/348578/zacks-value-trader-highlights-crocs-five-below-abbvie-and-jjill?cid=CS-ZC-FT-348578 Jan 21, 2019 - Zacks Value Trader Highlights: Crocs, Five Below, AbbVie and J.Jill
What's in Store for Bristol-Myers (BMY) in Q4 Earnings? http://www.zacks.com/stock/news/348553/whats-in-store-for-bristol-myers-bmy-in-q4-earnings?cid=CS-ZC-FT-348553 Jan 21, 2019 - Performance of Opdivo and the recently announced acquisition of Celgene Corporation will be key areas of focus for the investors when Bristol-Myers (BMY) reports fourth-quarter results.
My Readers Round Up 4 'Safer' Dividend Dogs For January https://seekingalpha.com/article/4234260-readers-round-4-safer-dividend-dogs-january?source=feed_all_articles Jan 18, 2019 -
AbbVie (ABBV) Reports Next Week: Wall Street Expects Earnings Growth http://www.zacks.com/stock/news/348444/abbvie-abbv-reports-next-week-wall-street-expects-earnings-growth?cid=CS-ZC-FT-348444 Jan 18, 2019 - AbbVie (ABBV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Pages: 123456...160

Page 1>

Related Companies

Name Exchange Price Mkt Cap
ABT Abbott Laboratories NYSE $67.67 $118.71B
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
LLY Eli Lilly and Company NYSE $105.71 $113.53B
SNY Sanofi NYSE $43.75 $109.14B
MRK Merck & Company, Inc. NYSE $70.42 $187.28B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for AbbVie
ABBV - Google Finance https://www.google.com/finance?q=ABBV Industry related info and international coverage Summary News
ABBV - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=ABBV Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options